Table 4 Patient characteristics stratified by discharge status among AKI patients (n = 508)
Survive (n = 207) | Die or AMA (n = 301) | P value | |
|---|---|---|---|
Reimbursement | 0.02 | ||
Government officer | 16 (7.7%) | 15 (5.0%) | |
Out-of-pockets | 158 (76.3%) | 259 (86.1%) | |
SS, private insurances | 33 (15.9%) | 27 (9.0%) | |
Primary diagnosis | 0.003 | ||
Infectious diseases | 22 (10.6%) | 55 (18.3%) | 0.02 |
Gastrointestinal diseases | 34 (16.4%) | 24 (8.0%) | 0.003 |
Neurologic diseases | 14 (6.8%) | 37 (12.3%) | 0.04 |
Comorbidity | |||
HT | 60 (29.0%) | 119 (39.5%) | 0.01 |
DM | 46 (22.2%) | 114 (37.9%) | < 0.001 |
AKI staging | 0.03 | ||
1 | 33 (15.9%) | 26 (8.6%) | |
2 | 63 (30.4%) | 87 (28.9%) | |
3 | 111 (53.6%) | 188 (62.5%) | |
AKI etiology | |||
Renal hypoperfusion | 113 (54.6%) | 128 (42.5%) | 0.007 |
APACHE II score | 15.4 (6.9) | 20.3 (8.9) | < 0.001 |
Non-renal SOFA score | 3.4 (2.2) | 7.0 (3.4) | < 0.001 |
Vasopressors | 172 (83.1%) | 219 (72.8%) | 0.007 |
Mechanical ventilation | 14 (6.8%) | 84 (27.9%) | < 0.001 |
RRT | 18 (8.7%) | 8 (2.7%) | 0.002 |
Urine output (mL) | 600 (400, 1000) | 400 (200, 1000) | < 0.001 |
Diuretics | 72 (34.8%) | 38 (12.6%) | < 0.001 |